Cargando…
Combination of NOS- and PDK-Inhibitory Activity: Possible Way to Enhance Antitumor Effects
We have previously demonstrated a high antitumor potential of NOS inhibitor T1023 (1-isobutanoyl-2-isopropylisothiourea hydrobromide): antitumor antiangiogenic activity in several animal tumor models and its ability to synergistically enhance the antitumor effects of bevacizumab, cyclophosphamide an...
Autores principales: | Filimonova, Marina, Shitova, Anna, Soldatova, Olga, Shevchenko, Ljudmila, Saburova, Alina, Podosinnikova, Tatjana, Surinova, Valentina, Shegay, Petr, Kaprin, Andrey, Ivanov, Sergey, Filimonov, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775993/ https://www.ncbi.nlm.nih.gov/pubmed/35054914 http://dx.doi.org/10.3390/ijms23020730 |
Ejemplares similares
-
Preclinical studies of NOS inhibitor T1059 vasopressor activity on the models of acute hemorrhagic shock in rats and dogs
por: Filimonova, Marina, et al.
Publicado: (2022) -
1-Isobutanoil-2-isopropylisothiourea Phosphate, T1082: A Safe and Effective Prevention of Radiotherapy Complications in Oncology
por: Filimonova, Marina, et al.
Publicado: (2022) -
The Ability of the Nitric Oxide Synthases Inhibitor T1023 to Selectively Protect the Non-Malignant Tissues
por: Filimonova, Marina, et al.
Publicado: (2021) -
Evaluation of In Vitro Cytotoxic Potential of Avarol towards Human Cancer Cell Lines and In Vivo Antitumor Activity in Solid Tumor Models
por: Stanojkovic, Tatjana P., et al.
Publicado: (2022) -
Non-peptide compounds from Kronopolites svenhedini (Verhoeff) and their antitumor and iNOS inhibitory activities
por: Yuan, Yuan-Nan, et al.
Publicado: (2023)